GOSSVSOBIO• 6 Months (Normalized)
GOSS vs OBIO (Gossamer Bio Inc. vs Orchestra BioMed Holdings Inc.)
Showing Closing Date Range from Mar, 19 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GOSS Performance $10.8
+2289.38%
Gossamer Bio Inc.
Normalized Baseline0.00%
OBIO Performance $5.95
+28.23%
Orchestra BioMed Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
+2261.15%
GOSS outperforming by 2261.15%
GOSSOBIO
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GOSS OBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | GOSS Price | GOSS Gain (%) | OBIO Price | OBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $10.80 | +2289.38% | $5.95 | +28.23% | +2261.15% |
| Sep 14, 2026 | $10.70 | +2267.26% | $5.90 | +27.16% | +2240.10% |
| Sep 11, 2026 | $10.73 | +2273.89% | $6.12 | +31.90% | +2241.99% |
| Sep 10, 2026 | $11.36 | +2413.27% | $5.81 | +25.22% | +2388.05% |
| Sep 09, 2026 | $12.80 | +2731.86% | $5.45 | +17.46% | +2714.40% |
| Sep 08, 2026 | $14.40 | +3085.84% | $5.43 | +17.03% | +3068.81% |
| Sep 04, 2026 | $14.00 | +2997.35% | $5.08 | +9.48% | +2987.87% |
| Sep 03, 2026 | $14.05 | +3007.96% | $4.74 | +2.16% | +3005.80% |
| Sep 02, 2026 | $0.17 | -61.73% | $4.95 | +6.68% | -68.41% |
| Sep 01, 2026 | $0.17 | -63.05% | $4.90 | +5.60% | -68.65% |
| Aug 31, 2026 | $0.17 | -62.39% | $5.04 | +8.62% | -71.01% |
| Aug 28, 2026 | $0.17 | -62.39% | $5.19 | +11.75% | -74.14% |
| Aug 27, 2026 | $0.17 | -62.39% | $5.11 | +10.13% | -72.52% |
| Aug 26, 2026 | $0.17 | -61.50% | $5.26 | +13.36% | -74.86% |
| Aug 25, 2026 | $0.21 | -54.65% | $5.36 | +15.52% | -70.17% |
Page 1 of 9